Sector
PharmaceuticalsOpen
₹208.92Prev. Close
₹206.76Turnover(Lac.)
₹74.4Day's High
₹213.39Day's Low
₹208.252 Week's High
₹245.752 Week's Low
₹148.5Book Value
₹67.56Face Value
₹5Mkt Cap (₹ Cr.)
1,055.61P/E
22.3EPS
9.45Divi. Yield
0.71Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 25.06 | 25.06 | 25.06 | 25.06 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 266.16 | 216.17 | 188.72 | 165.59 |
Net Worth | 291.22 | 241.23 | 213.78 | 190.65 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 431.96 | 306.95 | 238.07 | 206.14 |
yoy growth (%) | 40.72 | 28.93 | 15.48 | -36.8 |
Raw materials | -329.79 | -230.16 | -180.79 | -150.61 |
As % of sales | 76.34 | 74.98 | 75.93 | 73.06 |
Employee costs | -14.29 | -13.36 | -9 | -7.21 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 38.55 | 19.15 | 23.41 | 27.58 |
Depreciation | -15.07 | -7.03 | -1.83 | -1.96 |
Tax paid | -10.11 | -4.85 | -6.9 | -7.53 |
Working capital | 61.47 | -22.96 | 11.14 | -7.43 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 40.72 | 28.93 | 15.48 | -36.8 |
Op profit growth | 95.81 | 27.2 | -18.66 | -40.08 |
EBIT growth | 100.75 | -14.96 | -15.1 | -27.25 |
Net profit growth | 98.78 | -13.36 | -17.64 | -22.29 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Vice Chairman
Bipin N Shah
Non-Exec & Non-Independent Dir
Bharat N Shah
Chairman (Non-Executive)
Arun L Todarwal
Non-Exec & Non-Independent Dir
Samir J Shah
Non-Exec & Non-Independent Dir
Ketan L Shah
Joint Managing Director
Ritesh B Shah
Joint Managing Director
Vivek B Shah
Non-Exec & Non-Independent Dir
Mita Dixit
Non-Exec. & Independent Dir.
Harmanbhai Tulsibhai Patel
Independent Director
Pradeep Thakur
Independent Director
Siddharth Shah
Non-Exec & Non-Independent Dir
Gaurav Shah
Company Sec. & Compli. Officer
Manan Jayesh Vadhan
3-A Shivsagar Estate,
North Wing Dr A B Road Worli,
Maharashtra - 400018
Tel: 91-22-6622 7575
Website: http://www.anuhpharma.com
Email: [email protected]
J/12 Ansa Indl Est,
Sakivihar Road, Sakinaka Andheri (E),
Mumbai - 400072
Tel: 91-22-8524914/852354
Website: www.bigshareonline.com
Email: [email protected]
Summary
Anuh Pharma Limited is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The Company is engaged in the business of manufacturing and selling of Bulk drugs and chemicals. Th...
Read More
Reports by Anuh Pharma Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.